Correction
Potential risk for developing severe COVID-19 disease among anabolic steroid users
Paper Information
Record ID:
49382
Author(s):
Journal:
Publication Date:
February 26, 2021
Retraction Date:
November 02, 2023
(2.0 years years ago)
Subjects:
Institutions:
Countries:
Article Type:
Publisher:
BMJ Publishing
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Retraction Reasons:
Nature of Retraction:
Correction
Retraction Notice:
10.1136/bcr-2021-241572corr1Citations (21)
21
Total Citations1
Post-Retraction(4.8%)
20
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
62
Days since retraction (latest)
Impact of anabolic androgenic steroids on COVID-19
Khaja Moinuddin Shaik, Vijay Patibandla, Sukhendu Nandi
Steroids
Published: Jan 2024
2 citations
2 citations
62 days after retraction
Effects of Sex and Androgenic Drugs on the Expression of Angiotensin-Converting Enzyme 2 Receptor, Cathepsin l and Transmembrane Serine Protease in Mouse Lungs
Yazun Jarrar, Dana Alnajjar, Qais Jarrar et al. (8 authors)
Jordan Medical Journal
Open Access
Published: Jul 2023
122 days before retraction
The Problem with Capitalism in the Trichological Sciences
Ralph M. Trüeb, Aida Gadzhigoroeva, Daisy Kopera et al. (5 authors)
International Journal of Trichology
Open Access
Published: May 2023
185 days before retraction
The Hair and Scalp in Systemic Infectious Disease
Ralph M. Trüeb, Maria Fernanda Reis Gavazzoni Dias, Hudson Dutra Rezende et al. (5 authors)
Springer eBooks
Published: Jan 2023
3 citations
3 citations
305 days before retraction
Heart Disease After Covid: Exacerbated Future Health Risks Aligned to Previous and Existing AAS/Androgen Use
Philippe Crisp, Jamie Sims
Acta Facultatis Educationis Physicae Universitatis Comenianae
Open Access
Published: Nov 2022
366 days before retraction
Androgens’ Role in Severity and Mortality Rates of COVID-19
Ali Ataei, Mohammad Moein Derakhshan, Mohadese Razmjooie et al. (10 authors)
Hormone and Metabolic Research
Open Access
Published: Oct 2022
5 citations
5 citations
394 days before retraction
Fatal Form of COVID-19 in a Young Male Bodybuilder Anabolic Steroid Using: The First Autopsied Case
Costel Vasile Siserman, Ionuț Isaia Jeican, Dan Gheban et al. (11 authors)
Medicina
Open Access
Published: Sep 2022
3 citations
3 citations
399 days before retraction
An otherwise healthy male developed COVID-19 disease after the use of anabolic steroid: The second case report
Maher Al-Hajjaj, Oula Abou Alam, Muna Alqralleh et al. (5 authors)
Annals of Medicine and Surgery
Open Access
Published: Sep 2022
3 citations
3 citations
420 days before retraction
“MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
Pierre Kory, G. Umberto Meduri, José Iglesias et al. (6 authors)
Journal of Clinical Medicine Research
Open Access
Published: Feb 2022
7 citations
7 citations
639 days before retraction
Potential Association between the Use of Anabolic Steroids and COVID-19 Infection
Yusuf S. Althobaiti, Mohammad S. Alzahrani, Shahad M. Alhumayani et al. (6 authors)
Healthcare
Open Access
Published: Jan 2022
7 citations
7 citations
651 days before retraction
Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
Flavio Cadegiani, Ricardo Ariel Zimerman, Daniel Fonseca et al. (15 authors)
Cureus
Open Access
Published: Dec 2021
25 citations
25 citations
677 days before retraction
Investigating the impact of COVID-19 on performance and image enhancing drug use
Matthew Dunn, Timothy Piatkowski
Harm Reduction Journal
Open Access
Published: Dec 2021
27 citations
27 citations
701 days before retraction
Covid-19: Trial of experimental “covid cure” is among worst medical ethics violations in Brazil’s history, says regulator
Luke Taylor
BMJ
Published: Nov 2021
8 citations
8 citations
715 days before retraction
Public health concerns and increased risk of severe COVID-19 disease through androgen use
Philippe Crisp, Jamie Sims
Current Opinion in Endocrinology Diabetes and Obesity
Open Access
Published: Sep 2021
3 citations
3 citations
773 days before retraction
Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier et al. (4 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
6 citations
6 citations
830 days before retraction
RETRACTED: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
John McCoy, Andy Goren, Flavio Cadegiani et al. (15 authors)
Frontiers in Medicine
Open Access
Published: Jul 2021
46 citations
46 citations
836 days before retraction
Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier et al. (4 authors)
New Microbes and New Infections
Open Access
Published: Jul 2021
27 citations
27 citations
848 days before retraction
Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca, Michael do Nascimento Correia et al. (18 authors)
medRxiv (Cold Spring Harbor Laboratory)
Published: Jul 2021
5 citations
5 citations
853 days before retraction
Letter to the Editor re: Baldassarri et al., 2021 “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
Soha Ghanian, Carlos Gustavo Wambier
EBioMedicine
Open Access
Published: Jun 2021
1 citation
1 citation
884 days before retraction
Letter to the Editor on “COVID-19 Infection in Men on Testosterone Replacement Therapy”
Scott MacDonald, Carlos Gustavo Wambier
The Journal of Sexual Medicine
Open Access
Published: Mar 2021
1 citation
1 citation
959 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #49381
Nov 09, 2023Quick Stats
Total Citations:
21
Years Since Retraction:
2.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025